-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Equal-Weight on Medpace Holdings, Raises Price Target to $675

Benzinga·10/23/2026 13:34:26
语音播报
Barclays analyst Luke Sergott maintains Medpace Holdings (NASDAQ:MEDP) with a Equal-Weight and raises the price target from $625 to $675.